AbbVie | ABBV - Stammkapital





Stammkapital Veränderung Datum
AbbVie USD 1.77B 608K 2026-06
Abbott USD 1.74B 2.94M 2026-03
ALKERMES USD 168.03M 489K 2026-09
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
J&J USD 2.41B 1.64M 2026-06
Medtronic USD 1.28B 130K 2026-06
Merck USD 2.47B 1.05M 2026-06
Neurocrine Biosciences USD 101.3M 750K 2026-09
Novartis USD 1.89B 12.09M 2026-09
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.8M 700K 2026-09
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 0 2026-09
UCB EUR 190.36M 365.15K 2025-12
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
United Therapeutics USD 42.38M 295K 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Zoetis USD 407.49M 6.67M 2026-09